Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Thomas Roush

Orthopaedic Surgery West Palm Beach, FL Medical Doctor

NPI 1942240965 CMS profile 42714

1818 S Australian Ave, Suite 108, West Palm Beach, FL 33409

Open in the dashboard

General payments

$117,530

178 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Thomas Roush of West Palm Beach, FL is reported in the CMS Open Payments database as having received $117,530 across 178 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,122 61
2024 General $14,563 27
2023 General $33,062 26
2022 General $18,044 27
2021 General $11,940 25
2020 General $13,758 7
2019 General $11,041 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thomas Roush
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Thomas Roush were reported at $15,122. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Thomas Roush Orthopaedic Surgery median Middle half National median
2019 $11,041 $644 $140–$2,844 $163
2020 $13,758 $312 $75–$1,860 $114
2021 $11,940 $520 $117–$2,495 $132
2022 $18,044 $598 $128–$2,731 $149
2023 $33,062 $461 $128–$2,264 $160
2024 $14,563 $497 $134–$2,475 $164
2025 $15,122 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. NuVasive, Inc. $61,495 29 payments
  2. Globus Medical, Inc. $27,149 8 payments
  3. Centinel Spine, LLC $23,963 13 payments
  4. BIOTRONIK NRO, Inc. $2,466 81 payments
  5. Abbott Laboratories $1,805 34 payments
  6. AcelRx Pharmaceuticals, Inc. $322 5 payments
  7. Medacta USA, Inc. $137 1 payment
  8. OsteoCentric Technologies, Inc. $73 1 payment
  9. Pfizer Inc. $41 2 payments
  10. Vertical Pharmaceuticals, LLC $34 2 payments
  11. Other $45 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $87,773 26 payments
  2. Consulting Fee $22,750 4 payments
  3. Food and Beverage $6,107 145 payments
  4. Travel and Lodging $901 3 payments
Products named General payments · program years 2019–2025
  1. MLX Spine/Spine Surgery $63,396 19 payments
  2. MLX Spine/Spine Surgery $24,377 7 payments
  3. PRODISC L $20,555 6 payments
  4. PRODISC C $2,800 1 payment
  5. Prospera Not Applicable $1,501 52 payments
  6. PROCLAIM $1,187 15 payments
  7. Prospera Not Applicable $767 22 payments
  8. Proclaim IPG $618 19 payments
  9. PRODISC C VIVO $583 5 payments
  10. Simplify Cervical Artificial Disc $365 6 payments
  11. Other $978 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

332

Median for Orthopaedic Surgery: 30

Drug cost

$2,457

Median for Orthopaedic Surgery: $176

Branded share of claims

32.2%

Median for Orthopaedic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 96 $896
Diclofenac Sodium Generic 32 $385
Ibuprofen Generic 49 $290
Tramadol Hcl Generic 50 $282
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $140
Tizanidine Hcl Generic 14 $116
Gabapentin Generic 12 $88
Meloxicam Generic 14 $84
Pregabalin Generic 11 $66
Cephalexin Generic 30 $65

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,233 Part D prescribers listed as Orthopaedic Surgery; they describe a distribution and say nothing about conduct.

Records

178 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record